In this interview with Rachel Rakvica, VC firm founder Ariane Tom, explains that neuroscience is underserved in our healthcare systems today. Her company, Kaleida Capital, is keen to work with start-ups in neurotech to advance the understanding of how our brains work and to address issues such as neurodegeneration and psychiatric disorders, which have such a high economic burden. New studies show how the brain influences many aspects of our health, from immune function to chronic pain. Neural activity can influence and be influenced in a bidirectional manner, so this is an exciting time to be working in neurotech. Watch the full interview with Dr. Ariane Tom: https://lnkd.in/gcWwuuiy #Healthcare #ArtificialIntelligence #Neuroscience #MedicalDevices #DeepTech #Neuromodulation #AIinHealthcare
well done, Ariane.
Ariane Tom, PhD you are a rockstar !
Healthcare and MedTech Innovator @ Cambridge Consultants | Biostrategy, Biomanufacture
2moAdvancements in technology are revolutionizing our understanding of the brain and offering new avenues for treating neurodegenerative and psychiatric disorders. Continued investment in these technologies holds the promise of reducing the economic burden associated with these conditions.